United States Biotechnology & Medical Research

Harvard Apparatus Regenerative Technology Inc (HRGN)

Track

Track

Harvard Apparatus Regenerative Technology Inc. witnessed significant insider trading activity recently, with CEO He Junli executing two substantial buy orders totaling approximately $394,459 in September 2026. These acquisitions occurred amidst a 53.9% stock price increase over the last quarter, following the company's most recent results financiers reported in May.
Ticker: HRGN Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Harvard Apparatus Regenerative Technology Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.4
He Junli CEO Executive Director
Transaction date
Purchase
Price
210.35
Quantity 71,327 -22.4%
Value US$3,490,200
3.4
He Junli CEO Executive Director
Transaction date
Purchase
Price
233.44
Quantity 15,262 -1.6%
Value US$262,308
3.4
He Junli CEO Executive Director
Transaction date
Purchase
Price
315.90
Quantity 73,470 -42.5%
Value US$1,557,596
3.4
He Junli CEO Executive Director
Transaction date
Purchase
Price
1.98
Quantity 300 +0.1%
Value US$594
3.4
He Junli CEO Executive Director
Transaction date
Purchase
Price
1.85
Quantity 11,225 +4.2%
Value US$20,766
3.4
He Junli CEO Executive Director
Transaction date
Purchase
Price
1.72
Quantity 4,050 +1.5%
Value US$6,966
3.4
He Junli CEO Executive Director
Transaction date
Purchase
Price
2.87
Quantity 2,299 +0.9%
Value US$6,598
3.4
He Junli CEO Executive Director
Transaction date
Purchase
Price
3.37
Quantity 5,101 +2.0%
Value US$17,190
3.4
He Junli CEO Executive Director
Transaction date
Purchase
Price
2.80
Quantity 1,600 +0.6%
Value US$4,480
3.4
He Junli CEO Executive Director
Transaction date
Purchase
Price
4.76
Quantity 2,700 +1.1%
Value US$12,852
3.4
He Junli CEO Executive Director
Transaction date
Purchase
Price
4.92
Quantity 900 +0.4%
Value US$4,428
3.4
He Junli CEO Executive Director
Transaction date
Purchase
Price
5.07
Quantity 1,500 +0.6%
Value US$7,605
3.4
He Junli CEO Executive Director
Transaction date
Purchase
Price
5.43
Quantity 1,500 +0.6%
Value US$8,145
3.4
He Junli CEO Executive Director
Transaction date
Purchase
Price
4.69
Quantity 3,400 +1.4%
Value US$15,946
3.2
Shmerling James E. Non-Executive Director
Transaction date
Purchase
Price
4.35
Quantity 6,864 +40.6%
Value US$29,858
3.4
He Junli CEO Executive Director
Transaction date
Purchase
Price
4.32
Quantity 8,000 +3.4%
Value US$34,560
1.5
DST Capital LLC Large shareholder
Transaction date
Purchase
Price
6.00
Quantity 62,500 +1.7%
Value US$375,000
3.4
He Junli Non-Executive Director
Transaction date
Sale
Price
6.83
Quantity 135 -0.1%
Value US$922
3.1
Yu Hong PRESIDENT Officer
Transaction date
Sale
Price
7.17
Quantity 83,676 -27.3%
Value US$599,957
3.2
Chen Jing Non-Executive Director
Transaction date
Sale
Price
7.17
Quantity 48,532 -23.1%
Value US$347,974
1.5
DST Capital LLC Large shareholder
Transaction date
Sale
Price
7.17
Quantity 1,952 -0.1%
Value US$13,996
GREEN DAVID Interim CEO Executive Director
Transaction date
Purchase
Price
5.92
Quantity 63,345 +66.3%
Value US$375,002
3.2
Shmerling James E. Non-Executive Director
Transaction date
Purchase
Price
5.92
Quantity 16,892 +inf%
Value US$100,001
1.5
DST Capital LLC Large shareholder
Transaction date
Purchase
Price
5.92
Quantity 8,277 +0.2%
Value US$49,000
GREEN DAVID Interim CEO Executive Director
Transaction date
Purchase
Price
3.45
Quantity 72,464 +314.4%
Value US$250,001
1.5
DST Capital LLC Large shareholder
Transaction date
Purchase
Price
2.00
Quantity 150,000 +5.0%
Value US$300,000
DST Capital LLC Large shareholder
Transaction date
Purchase
Price
4.00
Quantity 5,000 +19.4%
Value US$20,000
Du Xiaoyu Large shareholder
Transaction date
Purchase
Price
3.60
Quantity 250,000 +50.0%
Value US$900,000
3.1
McNaughton Thomas Chief Financial Officer Officer
Transaction date
Purchase
Price
4.40
Quantity 2,500 +22.3%
Value US$11,000
3.1
Yu Hong President Officer
Transaction date
Purchase
Price
4.50
Quantity 4,705 +11.8%
Value US$21,172
Yu Hong President Officer
Transaction date
Purchase
Price
4.39
Quantity 14,645 +58.2%
Value US$64,292
3.1
Yu Hong President Officer
Transaction date
Purchase
Price
3.75
Quantity 650 +2.7%
Value US$2,438
McGorry James Joseph Chief Executive Officer Executive Director
Transaction date
Purchase
Price
4.00
Quantity 2,100 +26.4%
Value US$8,400
3.1
Yu Hong President Officer
Transaction date
Purchase
Price
3.82
Quantity 22,000 +873.0%
Value US$84,040
DST Capital LLC Large shareholder
Transaction date
Purchase
Price
3.26
Quantity 10,000 +63.6%
Value US$32,600
DST Capital LLC Large shareholder
Transaction date
Purchase
Price
2.67
Quantity 1,572 +11.1%
Value US$4,197
DST Capital LLC Large shareholder
Transaction date
Purchase
Price
2.60
Quantity 3,700 +35.4%
Value US$9,620
DST Capital LLC Large shareholder
Transaction date
Purchase
Price
2.20
Quantity 5,000 +91.7%
Value US$11,000
DST Capital LLC Large shareholder
Transaction date
Purchase
Price
2.16
Quantity 5,000 +1111.1%
Value US$10,800
DST Capital LLC Large shareholder
Transaction date
Purchase
Price
1.90
Quantity 200 +80.0%
Value US$380
LaFrancesca Saverio President and CMO Executive Director
Transaction date
Purchase
Price
0.37
Quantity 100,000 +51.5%
Value US$37,000
LaFrancesca Saverio President and CMO Executive Director
Transaction date
Purchase
Price
0.32
Quantity 150,000 +340.9%
Value US$48,000
0.7
DerSimonian Harout Chief Scientific Officer Officer
Transaction date
Purchase
Price
0.91
Quantity 10,000 +inf%
Value US$9,100
2.1
KENNEDY JOHN F Non-Executive Director
Transaction date
Purchase
Price
0.93
Quantity 16,182 +38.3%
Value US$15,033
McGorry James Joseph President and CEO Executive Director
Transaction date
Purchase
Price
0.96
Quantity 25,000 +24.7%
Value US$24,000
McGorry James Joseph President and CEO Executive Director
Transaction date
Purchase
Price
1.07
Quantity 20,000 +24.6%
Value US$21,400
1.1
Robinson Thomas H Non-Executive Director
Transaction date
Purchase
Price
1.17
Quantity 32,000 +177.8%
Value US$37,475
0.5
Canepa John J Non-Executive Director
Transaction date
Purchase
Price
1.46
Quantity 17,241 +inf%
Value US$25,172
3.1
McNaughton Thomas Chief Financial Officer Officer
Transaction date
Purchase
Price
1.55
Quantity 2,500 +1.2%
Value US$3,875
McGorry James Joseph President and CEO Executive Director
Transaction date
Purchase
Price
1.56
Quantity 10,000 +14.0%
Value US$15,600
2.1
KENNEDY JOHN F Non-Executive Director
Transaction date
Purchase
Price
1.56
Quantity 6,500 +18.2%
Value US$10,139
3.1
McNaughton Thomas Chief Financial Officer Officer
Transaction date
Purchase
Price
1.56
Quantity 2,500 +1.2%
Value US$3,900
1.1
Robinson Thomas H Non-Executive Director
Transaction date
Purchase
Price
1.36
Quantity 18,000 +inf%
Value US$24,401
LaFrancesca Saverio Chief Medical Officer Officer
Transaction date
Purchase
Price
2.01
Quantity 2,393 +5.8%
Value US$4,817
LaFrancesca Saverio Chief Medical Officer Officer
Transaction date
Sale
Price
1.93
Quantity 2,393 -5.4%
Value US$4,615
2.1
KENNEDY JOHN F Non-Executive Director
Transaction date
Purchase
Price
2.95
Quantity 9,000 +33.7%
Value US$26,525
LaFrancesca Saverio Chief Medical Officer Officer
Transaction date
Purchase
Price
3.01
Quantity 10,000 +29.4%
Value US$30,052
3.1
McNaughton Thomas Chief Financial Officer Officer
Transaction date
Purchase
Price
1.70
Quantity 10,000 +5.2%
Value US$17,000
McGorry James Joseph President and CEO Executive Director
Transaction date
Purchase
Price
1.79
Quantity 10,000 +16.3%
Value US$17,900
3.1
McNaughton Thomas Chief Financial Officer Officer
Transaction date
Purchase
Price
1.56
Quantity 10,000 +5.5%
Value US$15,600
3.1
McNaughton Thomas Chief Financial Officer Officer
Transaction date
Purchase
Price
1.32
Quantity 15,000 +9.0%
Value US$19,800
1.5
GREEN DAVID Non-Executive Director
Transaction date
Purchase
Price
1.34
Quantity 25,000 +8.7%
Value US$33,500
LaFrancesca Saverio Chief Medical Officer Officer
Transaction date
Purchase
Price
1.28
Quantity 4,500 +15.3%
Value US$5,760
LaFrancesca Saverio Chief Medical Officer Officer
Transaction date
Purchase
Price
1.29
Quantity 5,000 +20.4%
Value US$6,450
LaFrancesca Saverio Chief Medical Officer Officer
Transaction date
Purchase
Price
0.96
Quantity 2,500 +21.3%
Value US$2,400
3.1
McNaughton Thomas Chief Financial Officer Officer
Transaction date
Purchase
Price
0.88
Quantity 10,000 +6.4%
Value US$8,800
2.1
KENNEDY JOHN F Non-Executive Director
Transaction date
Purchase
Price
0.83
Quantity 12,000 +81.5%
Value US$9,960
McNaughton Thomas Chief Financial Officer Officer
Transaction date
Purchase
Price
0.76
Quantity 25,000 +19.1%
Value US$19,000
McGorry James Joseph President and CEO Executive Director
Transaction date
Purchase
Price
0.75
Quantity 26,300 +75.1%
Value US$19,725
McGorry James Joseph President and CEO Executive Director
Transaction date
Purchase
Price
0.66
Quantity 5,000 +16.7%
Value US$3,300
McNaughton Thomas Chief Financial Officer Officer
Transaction date
Purchase
Price
0.62
Quantity 75,000 +133.6%
Value US$46,500
KENNEDY JOHN F Non-Executive Director
Transaction date
Purchase
Price
2.13
Quantity 1,000 +7.3%
Value US$2,130
McNaughton Thomas Interim CEO & CFO Officer
Transaction date
Purchase
Price
2.01
Quantity 5,000 +9.8%
Value US$10,050
1.5
GREEN DAVID Non-Executive Director
Transaction date
Purchase
Price
1.98
Quantity 23,400 +8.8%
Value US$46,332
2.1
KENNEDY JOHN F Non-Executive Director
Transaction date
Purchase
Price
1.95
Quantity 1,000 +7.9%
Value US$1,950
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-25 2026-09-15 B Purchase
3.4
He Junli

CEO

Executive Director
71,327 -22.4%
210.35
US$3,490,200 		71,327 -22.4% 210.35 US$3,490,200
2026-09-25 2026-09-11 B Purchase
3.4
He Junli

CEO

Executive Director
15,262 -1.6%
233.44
US$262,308 		15,262 -1.6% 233.44 US$262,308
2025-12-01 2025-11-25 B Purchase
3.4
He Junli

CEO

Executive Director
73,470 -42.5%
315.90
US$1,557,596 		73,470 -42.5% 315.90 US$1,557,596
2025-10-01 2025-09-30 B Purchase
3.4
He Junli

CEO

Executive Director
300 +0.1%
1.98
US$594 		300 +0.1% 1.98 US$594
2025-09-24 2025-09-02 B Purchase
3.4
He Junli

CEO

Executive Director
11,225 +4.2%
1.85
US$20,766 		11,225 +4.2% 1.85 US$20,766
2025-09-02 2025-08-21 B Purchase
3.4
He Junli

CEO

Executive Director
4,050 +1.5%
1.72
US$6,966 		4,050 +1.5% 1.72 US$6,966
2025-01-02 2024-12-24 B Purchase
3.4
He Junli

CEO

Executive Director
2,299 +0.9%
2.87
US$6,598 		2,299 +0.9% 2.87 US$6,598
2024-09-12 2024-08-27 B Purchase
3.4
He Junli

CEO

Executive Director
5,101 +2.0%
3.37
US$17,190 		5,101 +2.0% 3.37 US$17,190
2024-07-02 2024-06-21 B Purchase
3.4
He Junli

CEO

Executive Director
1,600 +0.6%
2.80
US$4,480 		1,600 +0.6% 2.80 US$4,480
2024-01-03 2023-12-27 B Purchase
3.4
He Junli

CEO

Executive Director
2,700 +1.1%
4.76
US$12,852 		2,700 +1.1% 4.76 US$12,852
2023-12-18 2023-12-14 B Purchase
3.4
He Junli

CEO

Executive Director
900 +0.4%
4.92
US$4,428 		900 +0.4% 4.92 US$4,428
2023-12-11 2023-12-06 B Purchase
3.4
He Junli

CEO

Executive Director
1,500 +0.6%
5.07
US$7,605 		1,500 +0.6% 5.07 US$7,605
2023-09-18 2023-09-11 B Purchase
3.4
He Junli

CEO

Executive Director
1,500 +0.6%
5.43
US$8,145 		1,500 +0.6% 5.43 US$8,145
2023-09-05 2023-08-28 B Purchase
3.4
He Junli

CEO

Executive Director
3,400 +1.4%
4.69
US$15,946 		3,400 +1.4% 4.69 US$15,946
2023-08-23 2023-08-21 B Purchase
3.2
Shmerling James E.
Non-Executive Director
6,864 +40.6%
4.35
US$29,858 		6,864 +40.6% 4.35 US$29,858
2023-08-28 2023-08-18 B Purchase
3.4
He Junli

CEO

Executive Director
8,000 +3.4%
4.32
US$34,560 		8,000 +3.4% 4.32 US$34,560
2023-04-10 2023-04-06 B Purchase
1.5
DST Capital LLC
Large shareholder
62,500 +1.7%
6.00
US$375,000 		62,500 +1.7% 6.00 US$375,000
2023-01-05 2022-12-12 S Sale
3.4
He Junli
Non-Executive Director
135 -0.1%
6.83
US$922 		135 -0.1% 6.83 US$922
2022-12-09 2022-12-07 S Sale
3.1
Yu Hong

PRESIDENT

Officer
83,676 -27.3%
7.17
US$599,957 		83,676 -27.3% 7.17 US$599,957
2022-12-09 2022-12-07 S Sale
3.2
Chen Jing
Non-Executive Director
48,532 -23.1%
7.17
US$347,974 		48,532 -23.1% 7.17 US$347,974
2022-12-09 2022-12-07 S Sale
1.5
DST Capital LLC
Large shareholder
1,952 -0.1%
7.17
US$13,996 		1,952 -0.1% 7.17 US$13,996
2022-05-23 2022-05-12 B Purchase
GREEN DAVID

Interim CEO

Executive Director
63,345 +66.3%
5.92
US$375,002 		63,345 +66.3% 5.92 US$375,002
2022-05-23 2022-05-12 B Purchase
3.2
Shmerling James E.
Non-Executive Director
16,892 +inf%
5.92
US$100,001 		16,892 +inf% 5.92 US$100,001
2022-05-19 2022-05-12 B Purchase
1.5
DST Capital LLC
Large shareholder
8,277 +0.2%
5.92
US$49,000 		8,277 +0.2% 5.92 US$49,000
2021-11-30 2021-11-26 B Purchase
GREEN DAVID

Interim CEO

Executive Director
72,464 +314.4%
3.45
US$250,001 		72,464 +314.4% 3.45 US$250,001
2021-06-21 2021-06-17 B Purchase
1.5
DST Capital LLC
Large shareholder
150,000 +5.0%
2.00
US$300,000 		150,000 +5.0% 2.00 US$300,000
2018-07-16 2018-07-12 B Purchase DST Capital LLC Large shareholder
5,000 +19.4%
4.00
US$20,000 		5,000 +19.4% 4.00 US$20,000
2018-07-03 2018-06-29 B Purchase Du Xiaoyu Large shareholder
250,000 +50.0%
3.60
US$900,000 		250,000 +50.0% 3.60 US$900,000
2018-06-19 2018-06-15 B Purchase
3.1
McNaughton Thomas

Chief Financial Officer

Officer
2,500 +22.3%
4.40
US$11,000 		2,500 +22.3% 4.40 US$11,000
2018-06-18 2018-06-15 B Purchase
3.1
Yu Hong

President

Officer
4,705 +11.8%
4.50
US$21,172 		4,705 +11.8% 4.50 US$21,172
2018-06-18 2018-06-14 B Purchase Yu Hong

President

Officer
14,645 +58.2%
4.39
US$64,292 		14,645 +58.2% 4.39 US$64,292
2018-06-14 2018-06-13 B Purchase
3.1
Yu Hong

President

Officer
650 +2.7%
3.75
US$2,438 		650 +2.7% 3.75 US$2,438
2018-06-14 2018-06-12 B Purchase McGorry James Joseph

Chief Executive Officer

Executive Director
2,100 +26.4%
4.00
US$8,400 		2,100 +26.4% 4.00 US$8,400
2018-06-14 2018-06-12 B Purchase
3.1
Yu Hong

President

Officer
22,000 +873.0%
3.82
US$84,040 		22,000 +873.0% 3.82 US$84,040
2018-03-02 2018-02-28 B Purchase DST Capital LLC Large shareholder
10,000 +63.6%
3.26
US$32,600 		10,000 +63.6% 3.26 US$32,600
2018-01-23 2018-01-22 B Purchase DST Capital LLC Large shareholder
1,572 +11.1%
2.67
US$4,197 		1,572 +11.1% 2.67 US$4,197
2018-01-22 2018-01-19 B Purchase DST Capital LLC Large shareholder
3,700 +35.4%
2.60
US$9,620 		3,700 +35.4% 2.60 US$9,620
2018-01-22 2018-01-17 B Purchase DST Capital LLC Large shareholder
5,000 +91.7%
2.20
US$11,000 		5,000 +91.7% 2.20 US$11,000
2018-01-16 2018-01-12 B Purchase DST Capital LLC Large shareholder
5,000 +1111.1%
2.16
US$10,800 		5,000 +1111.1% 2.16 US$10,800
2018-01-16 2018-01-11 B Purchase DST Capital LLC Large shareholder
200 +80.0%
1.90
US$380 		200 +80.0% 1.90 US$380
2017-08-25 2017-08-24 B Purchase LaFrancesca Saverio

President and CMO

Executive Director
100,000 +51.5%
0.37
US$37,000 		100,000 +51.5% 0.37 US$37,000
2017-08-24 2017-08-23 B Purchase LaFrancesca Saverio

President and CMO

Executive Director
150,000 +340.9%
0.32
US$48,000 		150,000 +340.9% 0.32 US$48,000
2016-10-14 2016-10-12 B Purchase
0.7
DerSimonian Harout

Chief Scientific Officer

Officer
10,000 +inf%
0.91
US$9,100 		10,000 +inf% 0.91 US$9,100
2016-08-29 2016-08-26 B Purchase
2.1
KENNEDY JOHN F
Non-Executive Director
16,182 +38.3%
0.93
US$15,033 		16,182 +38.3% 0.93 US$15,033
2016-08-25 2016-08-25 B Purchase McGorry James Joseph

President and CEO

Executive Director
25,000 +24.7%
0.96
US$24,000 		25,000 +24.7% 0.96 US$24,000
2016-06-22 2016-06-21 B Purchase McGorry James Joseph

President and CEO

Executive Director
20,000 +24.6%
1.07
US$21,400 		20,000 +24.6% 1.07 US$21,400
2016-06-14 2016-06-13 B Purchase
1.1
Robinson Thomas H
Non-Executive Director
32,000 +177.8%
1.17
US$37,475 		32,000 +177.8% 1.17 US$37,475
2016-05-26 2016-05-25 B Purchase
0.5
Canepa John J
Non-Executive Director
17,241 +inf%
1.46
US$25,172 		17,241 +inf% 1.46 US$25,172
2016-05-23 2016-05-20 B Purchase
3.1
McNaughton Thomas

Chief Financial Officer

Officer
2,500 +1.2%
1.55
US$3,875 		2,500 +1.2% 1.55 US$3,875
2016-05-23 2016-05-20 B Purchase McGorry James Joseph

President and CEO

Executive Director
10,000 +14.0%
1.56
US$15,600 		10,000 +14.0% 1.56 US$15,600
2016-05-23 2016-05-20 B Purchase
2.1
KENNEDY JOHN F
Non-Executive Director
6,500 +18.2%
1.56
US$10,139 		6,500 +18.2% 1.56 US$10,139
2016-05-23 2016-05-20 B Purchase
3.1
McNaughton Thomas

Chief Financial Officer

Officer
2,500 +1.2%
1.56
US$3,900 		2,500 +1.2% 1.56 US$3,900
2016-05-20 2016-05-19 B Purchase
1.1
Robinson Thomas H
Non-Executive Director
18,000 +inf%
1.36
US$24,401 		18,000 +inf% 1.36 US$24,401
2015-12-18 2015-12-17 B Purchase LaFrancesca Saverio

Chief Medical Officer

Officer
2,393 +5.8%
2.01
US$4,817 		2,393 +5.8% 2.01 US$4,817
2015-12-18 2015-12-17 S Sale LaFrancesca Saverio

Chief Medical Officer

Officer
2,393 -5.4%
1.93
US$4,615 		2,393 -5.4% 1.93 US$4,615
2015-12-01 2015-12-01 B Purchase
2.1
KENNEDY JOHN F
Non-Executive Director
9,000 +33.7%
2.95
US$26,525 		9,000 +33.7% 2.95 US$26,525
2015-12-01 2015-12-01 B Purchase LaFrancesca Saverio

Chief Medical Officer

Officer
10,000 +29.4%
3.01
US$30,052 		10,000 +29.4% 3.01 US$30,052
2015-11-19 2015-11-19 B Purchase
3.1
McNaughton Thomas

Chief Financial Officer

Officer
10,000 +5.2%
1.70
US$17,000 		10,000 +5.2% 1.70 US$17,000
2015-11-19 2015-11-19 B Purchase McGorry James Joseph

President and CEO

Executive Director
10,000 +16.3%
1.79
US$17,900 		10,000 +16.3% 1.79 US$17,900
2015-11-18 2015-11-18 B Purchase
3.1
McNaughton Thomas

Chief Financial Officer

Officer
10,000 +5.5%
1.56
US$15,600 		10,000 +5.5% 1.56 US$15,600
2015-11-17 2015-11-17 B Purchase
3.1
McNaughton Thomas

Chief Financial Officer

Officer
15,000 +9.0%
1.32
US$19,800 		15,000 +9.0% 1.32 US$19,800
2015-11-17 2015-11-17 B Purchase
1.5
GREEN DAVID
Non-Executive Director
25,000 +8.7%
1.34
US$33,500 		25,000 +8.7% 1.34 US$33,500
2015-09-21 2015-09-18 B Purchase LaFrancesca Saverio

Chief Medical Officer

Officer
4,500 +15.3%
1.28
US$5,760 		4,500 +15.3% 1.28 US$5,760
2015-09-21 2015-09-18 B Purchase LaFrancesca Saverio

Chief Medical Officer

Officer
5,000 +20.4%
1.29
US$6,450 		5,000 +20.4% 1.29 US$6,450
2015-09-01 2015-08-28 B Purchase LaFrancesca Saverio

Chief Medical Officer

Officer
2,500 +21.3%
0.96
US$2,400 		2,500 +21.3% 0.96 US$2,400
2015-08-27 2015-08-26 B Purchase
3.1
McNaughton Thomas

Chief Financial Officer

Officer
10,000 +6.4%
0.88
US$8,800 		10,000 +6.4% 0.88 US$8,800
2015-08-24 2015-08-24 B Purchase
2.1
KENNEDY JOHN F
Non-Executive Director
12,000 +81.5%
0.83
US$9,960 		12,000 +81.5% 0.83 US$9,960
2015-08-21 2015-08-21 B Purchase McNaughton Thomas

Chief Financial Officer

Officer
25,000 +19.1%
0.76
US$19,000 		25,000 +19.1% 0.76 US$19,000
2015-08-21 2015-08-21 B Purchase McGorry James Joseph

President and CEO

Executive Director
26,300 +75.1%
0.75
US$19,725 		26,300 +75.1% 0.75 US$19,725
2015-08-21 2015-08-20 B Purchase McGorry James Joseph

President and CEO

Executive Director
5,000 +16.7%
0.66
US$3,300 		5,000 +16.7% 0.66 US$3,300
2015-08-21 2015-08-19 B Purchase McNaughton Thomas

Chief Financial Officer

Officer
75,000 +133.6%
0.62
US$46,500 		75,000 +133.6% 0.62 US$46,500
2015-06-08 2015-06-04 B Purchase KENNEDY JOHN F Non-Executive Director
1,000 +7.3%
2.13
US$2,130 		1,000 +7.3% 2.13 US$2,130
2015-06-03 2015-06-03 B Purchase McNaughton Thomas

Interim CEO & CFO

Officer
5,000 +9.8%
2.01
US$10,050 		5,000 +9.8% 2.01 US$10,050
2015-06-03 2015-06-03 B Purchase
1.5
GREEN DAVID
Non-Executive Director
23,400 +8.8%
1.98
US$46,332 		23,400 +8.8% 1.98 US$46,332
2015-06-03 2015-06-03 B Purchase
2.1
KENNEDY JOHN F
Non-Executive Director
1,000 +7.9%
1.95
US$1,950 		1,000 +7.9% 1.95 US$1,950
Explore more

More insider trading research around Harvard Apparatus Regenerative Technology Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America